<DOC>
	<DOCNO>NCT02862886</DOCNO>
	<brief_summary>CHRONOLOGICAL DESCRIPTION OF THE STUDY 1 . Information provide study participant 2 . Collection write informed consent 3 . Harvesting myometrial biopsy 4 . Creation tissue explants use myometrial biopsy 5 . Stimulation explants LPS 6 . Study effect SAR150640 ( beta3-adrenergic agonist ) LPS-induced oxidative stress Moreover , demonstrate ability beta3-adrenergic receptor agonist prevent appearance oxidative stress consequence tissue , complement previous study , additional argument clinical development class pharmaceutical management threaten premature delivery labour induction .</brief_summary>
	<brief_title>Study Effect Beta-3 Adrenergic Receptor Agonists Oxidative Stress Signalling Pathways Implicated Remodelling Uteroplacental Space : Experimental Vitro Approach Myometrial Tissue Explants</brief_title>
	<detailed_description />
	<mesh_term>Adrenergic Agents</mesh_term>
	<mesh_term>Adrenergic Agonists</mesh_term>
	<criteria>Signed informed consent Patients national health insurance cover Patients normal pregnancy require caesarean section obstetrical reason No obvious infectious context Obvious inflammatory autoimmune disease Suspected confirm infectious context , include HIV , HCV HBV Coagulation disorder Preexisting gestational diabetes</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>